Holen Sie sich die Stockscreener-App
19.56
0.82%
0.16
Schlusskurs vom Vortag:
$19.40
Offen:
$19.67
24-Stunden-Volumen:
11.51M
Relative Volume:
1.26
Marktkapitalisierung:
$13.49B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
61.36
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
-4.59%
1M Leistung:
+0.36%
6M Leistung:
+19.20%
1J Leistung:
+14.72%
1-Tages-Spanne:
$19.43
$19.73
1-Wochen-Bereich:
$19.31
$20.80
52-Wochen-Spanne:
$15.70
$20.82
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
19.56 | 13.49B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
206.65 | 145.88B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
81.60 | 39.67B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
44.53 | 13.26B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
46.52 | 9.62B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
How Is Healthpeak Properties' Stock Performance Compared to Other Real Estate Stocks? - Barchart.com
Healthpeak Properties: This 6% Yielding REIT Has More Room To Run - Seeking Alpha
Why the Del Rey life science campus from Healthpeak Properties feels built for scientists, not sprea - AD HOC NEWS
Why one South San Francisco lab keeps drawing biotech, Healthpeak’s Sierra Point standout - AD HOC NEWS
Healthpeak Properties Publishes Its 15th Annual Corporate Impact Report - Business Wire
Healthpeak Properties StockWeekly review and sector comparison - AD HOC NEWS
Why Healthpeak Properties leans on its medical office portfolio for steady rent - AD HOC NEWS
Healthpeak Properties Inc (DOC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Healthpeak Properties Inc (DOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Healthpeak Properties Inc (DOC) Shares Fall 3.4% -- What GF Scor - GuruFocus
Healthpeak Properties Inc (DOC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
BMO Capital and Morgan Stanley Take Different Views on Healthpeak Properties (DOC) - Insider Monkey
DOC Reinstated by Raymond James -- Rating Set to Market Perform - GuruFocus
Why Healthpeak Properties' Scripps Medical Center quietly matters for everyday patients - AD HOC NEWS
Healthpeak Properties (DOC) Receives Market Perform Rating from Raymond James - GuruFocus
Healthpeak Properties Inc (DOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lifestyle twist for senior living, Janus Living private-pay portfolio expands Healthpeak’s reach - AD HOC NEWS
VIP DISCIPLINED SMALL CAP PORTFOLIO's Healthpeak Properties Inc(DOC) Holding History - GuruFocus
Healthpeak Properties to report Q2FY26 results on August 4 - scanx.trade
Healthpeak Properties Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast - Yahoo Finance
DOC Maintained by BMO Capital -- Price Target Raised to $24 - GuruFocus
Healthpeak Properties Stock (US42226K1051): analyst upgrade and ex-dividend date put income REIT in - AD HOC NEWS
BMO Capital Adjusts PT on Healthpeak Properties to $24 From $20, Maintains Outperform Rating - marketscreener.com
Jim Cramer Highlights Healthpeak Properties and Its Strong Dividend Yield - Insider Monkey
Healthpeak Properties, Inc.: - marketscreener.com
Healthpeak Properties Stock (US42226K1051): dividend-focused healthcare REIT stays in focus after re - AD HOC NEWS
Healthpeak Properties (DOC) Downgraded by Morgan Stanley Amid Ma - GuruFocus
Healthpeak Properties Stock (US42250P1030): Valuation in focus after REIT sector repricing - AD HOC NEWS
HCP Changes Name to Healthpeak Properties - Nareit
Morgan Stanley downgrades two life sciences REITs over limited visibility on lab market recovery (ARE:NYSE) - Seeking Alpha
Healthpeak Properties Q1 FFOA tops estimates on steady leasing momentum - MSN
What's in the cards for Healthpeak Properties this earnings season? - MSN
Morgan Stanley downgrades Healthpeak Properties stock rating on valuation By Investing.com - Investing.com Nigeria
Morgan Stanley downgrades Healthpeak Properties stock rating on valuation - Investing.com
Morgan Stanley Downgrades Healthpeak Properties(DOC.US) to Hold Rating, Raises Target Price to $22 - Moomoo
Healthpeak Properties stock hits 52-week high at 20.28 USD By Investing.com - Investing.com South Africa
A Look at Healthpeak Properties Inc (DOC) After 3.7% Gain -- GF Value $19.54 vs Price $20.50 - GuruFocus
Healthpeak Properties Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties stock hits 52-week high at 20.28 USD - Investing.com
How Investors Are Reacting To Healthpeak Properties (DOC) Higher FFOA Outlook And Janus Living IPO Windfall - Sahm
Healthpeak Properties offers stable growth and ... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner - Seeking Alpha
How Investors Are Reacting To Healthpeak Properties (DOC) Raised 2026 FFOA Outlook And Janus Living IPO Proceeds - Yahoo Finance
Is It Time To Reassess Healthpeak Properties (DOC) After Its Strong Year To Date Rally - Yahoo Finance
Healthpeak Properties, Inc. - MLQ.ai
Healthpeak IPO Of Janus Living Reshapes Portfolio And Lifts 2026 Outlook - Sahm
DOC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Earnings call transcript: Healthpeak Properties’ Q1 2026 earnings soar, stock surges - Investing.com
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Healthpeak Enhances Sustainability Through Green Bonds - Nareit
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):